At a glance
ClinicalIndex Comparison RecordN/ACompleted· 18 enrolled
Drug / intervention
Krill Oil +4 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Postprandial Modulation of HDL Metabolism
In Brief
A clinical study evaluating Krill Oil, Lutein, and 3 other interventions for Dyslipidemia. Completed, enrolled 18 participants across 1 site.
Detailed Summary
This study involves measuring subject's blood lipid responses after they consume a mixture of dietary fats of marine and dairy origin and vitamin supplements mixed into a milkshake, on three separate days. The investigators hope to learn more about how different food ingredients influence the metabolism HDL in individuals with low blood levels of HDL cholesterol.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDyslipidemia
CountriesUnited States
CollaboratorsUnilever R&D
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2012
Primary CompletionJan 2013
First PostedMar 2013
Study CompletionMar 2015
TodayJul 2026
First PostedMar 4, 2013
Enrollment StartAug 1, 2012
Primary CompletionJan 2, 2013
Study CompletionMar 13, 2015
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 13.3 years ago
Interventions
Krill Oildietary
Neptune Krill Oil Gold
Luteindietary
Jarrow Formulas
Nicotinic aciddietary
Natures Way
Dairy phospholipidsdietary
PC700 manufactured by Fonterra
Controlother
Control shake without dietary supplements